gout
GOUT
Gout is a condition that resulted from deposition of monosodium urate crystals in various tissues (eg joints, connective tissue, kidney).
The patient experiences acute and chronic arthritis, soft tissue inflammation, tophus formation, gouty nephropathy and nephrolithiasis.
Primary hyperuricemia is called when uric acid saturation arises without coexisting diseases or drugs that alter uric acid production and excretion.
While in secondary hyperuricemia there is an excessive uric acid production or diminished renal clearance that occurs as a result of a disease, drug, dietary product or toxin.

Introduction

  • Gout is a condition wherein increased uric acid or urate in the body, also called hyperuricemia, leads to deposition of monosodium urate monohydrate (MSU) crystals in various tissues (eg joints, connective tissue, kidney)
  • Hyperuricemia is a necessary precondition for the development of MSU crystal deposition but this has to be distinguished from gout, the clinical syndrome
  • Results in acute and chronic inflammation associated with changes in articular & periarticular structures
  • Affects up to 1-2% of adults & is the most common inflammatory arthritis in men
Editor's Recommendations
Most Read Articles
4 months ago
Erectile dysfunction may potentially be associated with gout, a new systematic report and meta-analysis reveals. However, the low quality and high degree of heterogeneity among the studies included reduce the certainty of this conclusion.
5 days ago
Patients with juvenile-onset systemic lupus erythematosus (jSLE) have a higher frequency of renal involvement, cutaneous symptoms, oral ulcers, neuropsychiatric (NP) manifestations, autoimmune hemolytic anaemia (AIHA) and anti-dsDNA positivity than those with adult-onset SLE (aSLE), a recent study has found.
one month ago
At the International Osteoporosis Foundation Regionals – 6th Asia-Pacific Osteoporosis Meeting in Singapore, Professor Olivier Bruyère shared about the algorithm for the management of knee OA by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). MIMS Doctor also spoke to Professor Jean-Yves Reginster, president of ESCEO about this algorithm and the role of SYSADOAs in the control of pain and prevention of disease progression.
one month ago
The goal of this module is to provide an overview on ankylosing spondylitis. Click here to learn more.